Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Prot #MK4830-002-02: A Randomized, Phase 2 Study of Pembrolizumab And Chemotherapy With or Without MK-4830 as Neoadjuvant Treatment for High-Grade Serous Ovarian Cancer
Roque, Dario R
(PD/PI)
Obstetrics and Gynecology
Project
:
Research project
Overview
Project Details
Status
Active
Effective start/end date
10/27/22
→
10/27/25
Funding
Merck Sharp & Dohme LLC
(Prot #MK4830-002-02)
View all
View less